CRIS vs REPL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

CRIS

49.6
AI Score
VS
CRIS Wins

REPL

47.2
AI Score

Investment Advisor Scores

CRIS

50score
Recommendation
HOLD

REPL

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CRIS REPL Winner
Net Income -24.20M -10.04M REPL
Operating Income -11.52M -5.88M REPL
ROE -190.4% 26.0% REPL
ROA -81.5% -16.9% REPL
Total Assets 29.69M 59.29M REPL
Cash 15.00M 12.91M CRIS
Current Ratio 1.11 12.28 REPL

Relative Price Performance (Last 90 Days)

CRIS 1M: +1385.9% · 3M: +769.9% REPL 1M: +6.1% · 3M: +363.4%

Current Technical Phase

CRIS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (288.9% over 20 days), RSI 70

RSI (14): 70.0 · Price: $5.15

REPL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (38.5% over 20 days), RSI 59

RSI (14): 59.3 · Price: $11.91

Fundamentals Snapshot

Metric CRIS REPL
Market Cap
Forward P/E -0.3 -5.7
Trailing P/E
Revenue (TTM)
Revenue Growth -0.7% 0.0%
Gross Margin -2.7%
Operating Margin -4.9% 0.0%
EPS -11.76 -3.38
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CRIS is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.